Hi,
moomoo ID:NaN
Log Out
English
Back
Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > NVCR Novocure > Main Composition
NVCR Novocure
94.220
-0.870-0.91%
Post Mkt Price
94.2200.0000.00%
All
YOY
Do not show
Business Unit:USD
nameYOYOperating income%
Single segment--535.03M100.00%
Region Unit:USD
nameYOYOperating income%
United States--353.11M66.00%
Germany--93.94M17.56%
Japan--34.64M6.47%
Other EMEA--30.58M5.71%
Greater China--22.77M4.25%
Company Overview More
NovoCure Ltd. is an oncology company which engages in the development, manufacture, and commercialization of Optune for the treatment of a variety of solid tumors. Its platform is called the Tumor Treating Field which uses electric fields tuned to specific frequencies to disrupt solid tumor cancer cell division. The company was founded by Yoram Palti in 2000 and is headquartered in St. Helier, Jersey.
CEO: Mr. Asaf Danziger
Market: NASDAQ
Listing Date: 10/02/2015
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist